Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.

Hansen RW, Pedersen CB, Halle B, Korshoej AR, Schulz MK, Kristensen BW, Poulsen FR.

J Neurosurg. 2019 Oct 4:1-8. doi: 10.3171/2019.6.JNS191531. [Epub ahead of print]

PMID:
31585425
2.

Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.

Sievers P, Appay R, Schrimpf D, Stichel D, Reuss DE, Wefers AK, Reinhardt A, Coras R, Ruf VC, Schmid S, de Stricker K, Boldt HB, Kristensen BW, Petersen JK, Ulhøi BP, Gardberg M, Aronica E, Hasselblatt M, Brück W, Bielle F, Mokhtari K, Lhermitte B, Wick W, Herold-Mende C, Hänggi D, Brandner S, Giangaspero F, Capper D, Rushing E, Wesseling P, Pfister SM, Figarella-Branger D, von Deimling A, Sahm F, Jones DTW.

Acta Neuropathol. 2019 Sep;138(3):497-504. doi: 10.1007/s00401-019-02038-4. Epub 2019 Jun 27.

PMID:
31250151
3.

Molecular Pathology of Tumors of the Central Nervous System.

Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P.

Ann Oncol. 2019 May 24. pii: mdz164. doi: 10.1093/annonc/mdz164. [Epub ahead of print]

4.

[Pituitary adenoma].

Møller MW, Andersen MS, Glintborg D, Pedersen CB, Halle B, Kristensen BW, Poulsen FR.

Ugeskr Laeger. 2019 May 13;181(20). pii: V05180331. Danish.

PMID:
31124446
5.

Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival.

Dahlrot RH, Larsen P, Boldt HB, Kreutzfeldt MS, Hansen S, Hjelmborg JB, Kristensen BW.

J Neuropathol Exp Neurol. 2019 Jul 1;78(7):633-640. doi: 10.1093/jnen/nlz032.

PMID:
31058280
6.

Frameless stereotactic neuronavigated biopsy: A retrospective study of morbidity, diagnostic yield, and the potential of fluorescence: A single-center clinical investigation.

Æbelø AM, Noer VR, Schulz MK, Kristensen BW, Pedersen CB, Poulsen FR.

Clin Neurol Neurosurg. 2019 Jun;181:28-32. doi: 10.1016/j.clineuro.2019.03.004. Epub 2019 Mar 31.

PMID:
30981151
7.

A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response.

Gudbergsson JM, Kostrikov S, Johnsen KB, Fliedner FP, Stolberg CB, Humle N, Hansen AE, Kristensen BW, Christiansen G, Kjær A, Andresen TL, Duroux M.

Exp Cell Res. 2019 Jun 1;379(1):73-82. doi: 10.1016/j.yexcr.2019.03.031. Epub 2019 Mar 25.

PMID:
30922921
8.

Early postoperative MRI after resection of brain metastases-complete tumour resection associated with prolonged survival.

Olesrud IC, Schulz MK, Marcovic L, Kristensen BW, Pedersen CB, Kristiansen C, Poulsen FR.

Acta Neurochir (Wien). 2019 Mar;161(3):555-565. doi: 10.1007/s00701-019-03829-0. Epub 2019 Feb 13.

PMID:
30756241
9.

[Integrated diagnostics of brain tumours based on histological and molecular features].

Petersen JK, Scheie D, Boldt HB, Ulhøi BP, Ettrup MS, Kristensen BW.

Ugeskr Laeger. 2019 Feb 4;181(6). pii: V07180509. Danish.

PMID:
30729918
10.

[Intracranial meningiomas].

Andersen MS, Pedersen CB, Mathiesen T, Poulsgaard L, Kristensen BW, Halle B, Poulsen FR.

Ugeskr Laeger. 2019 Jan 21;181(4). pii: V07180489. Danish.

PMID:
30722833
11.

Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells.

Hey SM, Jensen P, Ryding M, Martínez Serrano A, Kristensen BW, Meyer M.

Eur J Neurosci. 2019 Feb;49(4):497-509. doi: 10.1111/ejn.14284. Epub 2018 Dec 8.

PMID:
30471165
12.

Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.

Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, Radivoyevitch T, Kornblum HI, Kristensen BW, Vogelbaum MA, Lathia JD.

JCI Insight. 2018 Nov 2;3(21). pii: 122264. doi: 10.1172/jci.insight.122264.

13.

Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival.

Beier CP, Rasmussen T, Dahlrot RH, Tenstad HB, Aarø JS, Sørensen MF, Heimisdóttir SB, Sørensen MD, Svenningsen P, Riemenschneider MJ, Beier D, Kristensen BW.

Sci Rep. 2018 Oct 8;8(1):14965. doi: 10.1038/s41598-018-33282-5.

14.

D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.

Zhang L, Sorensen MD, Kristensen BW, Reifenberger G, McIntyre TM, Lin F.

Clin Cancer Res. 2018 Nov 1;24(21):5381-5391. doi: 10.1158/1078-0432.CCR-17-3855. Epub 2018 Jul 13.

PMID:
30006485
15.

Intraoperative low field MRI in transsphenoidal pituitary surgery.

Møller MW, Andersen MS, Pedersen CB, Kristensen BW, Poulsen FR.

Endocr Connect. 2018 Jul;7(7):897-906. doi: 10.1530/EC-18-0140. Epub 2018 Jul 2.

16.

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.

Nielsen LAG, Bangsø JA, Lindahl KH, Dahlrot RH, Hjelmborg JVB, Hansen S, Kristensen BW.

Diagn Pathol. 2018 Jun 9;13(1):38. doi: 10.1186/s13000-018-0711-2.

17.

Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

Blaabjerg M, Hemdrup AL, Drici L, Ruprecht K, Garred P, Höftberger R, Kristensen BW, Kondziella D, Sejbaek T, Hansen SW, Nielsen HH, Jensen P, Meyer M, Paul F, Lassmann H, Larsen MR, Illes Z.

Front Immunol. 2018 Apr 23;9:741. doi: 10.3389/fimmu.2018.00741. eCollection 2018.

18.

Heterogenic expression of stem cell markers in patient-derived glioblastoma spheroid cultures exposed to long-term hypoxia.

Rosenberg T, Aaberg-Jessen C, Petterson SA, Kristensen BW.

CNS Oncol. 2018 Apr;7(2):CNS15. doi: 10.2217/cns-2017-0034. Epub 2018 Apr 30.

19.

DNA methylation-based classification of central nervous system tumours.

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM.

Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.

20.

Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.

Aaberg-Jessen C, Sørensen MD, Matos ALSA, Moreira JM, Brünner N, Knudsen A, Kristensen BW.

BMC Cancer. 2018 Mar 9;18(1):270. doi: 10.1186/s12885-018-4179-y.

21.

SuperQuant-assisted comparative proteome analysis of glioblastoma subpopulations allows for identification of potential novel therapeutic targets and cell markers.

Verano-Braga T, Gorshkov V, Munthe S, Sørensen MD, Kristensen BW, Kjeldsen F.

Oncotarget. 2018 Jan 25;9(10):9400-9414. doi: 10.18632/oncotarget.24321. eCollection 2018 Feb 6.

22.

High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.

Sørensen MF, Heimisdóttir SB, Sørensen MD, Mellegaard CS, Wohlleben H, Kristensen BW, Beier CP.

J Neurooncol. 2018 May;138(1):49-53. doi: 10.1007/s11060-018-2785-9. Epub 2018 Feb 5.

PMID:
29404978
23.

Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells.

Dreyer-Andersen N, Almeida AS, Jensen P, Kamand M, Okarmus J, Rosenberg T, Friis SD, Martínez Serrano A, Blaabjerg M, Kristensen BW, Skrydstrup T, Gramsbergen JB, Vieira HLA, Meyer M.

PLoS One. 2018 Jan 16;13(1):e0191207. doi: 10.1371/journal.pone.0191207. eCollection 2018.

24.

A 4-miRNA signature to predict survival in glioblastomas.

Hermansen SK, Sørensen MD, Hansen A, Knudsen S, Alvarado AG, Lathia JD, Kristensen BW.

PLoS One. 2017 Nov 14;12(11):e0188090. doi: 10.1371/journal.pone.0188090. eCollection 2017.

25.

Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.

Aaberg-Jessen C, Fogh L, Sørensen MD, Halle B, Brünner N, Kristensen BW.

Pathol Oncol Res. 2019 Jan;25(1):59-69. doi: 10.1007/s12253-017-0312-5. Epub 2017 Sep 30.

PMID:
28963609
26.

Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.

Rosager AM, Sørensen MD, Dahlrot RH, Hansen S, Schonberg DL, Rich JN, Lathia JD, Kristensen BW.

PLoS One. 2017 Aug 24;12(8):e0182954. doi: 10.1371/journal.pone.0182954. eCollection 2017.

27.

TLR4 in glioblastoma-when cancer stem cells ignore "danger signals".

Beier CP, Kristensen BW.

Stem Cell Investig. 2017 Jul 25;4:66. doi: 10.21037/sci.2017.07.01. eCollection 2017. No abstract available.

28.

Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.

Sørensen MD, Dahlrot RH, Boldt HB, Hansen S, Kristensen BW.

Neuropathol Appl Neurobiol. 2018 Feb;44(2):185-206. doi: 10.1111/nan.12428. Epub 2017 Sep 5.

PMID:
28767130
29.

Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region.

Casar-Borota O, Botling J, Granberg D, Stigare J, Wikström J, Boldt HB, Kristensen BW, Pontén F, Trouillas J.

Am J Surg Pathol. 2017 Sep;41(9):1238-1246. doi: 10.1097/PAS.0000000000000908.

PMID:
28719461
30.

Expression and prognostic value of JAM-A in gliomas.

Rosager AM, Sørensen MD, Dahlrot RH, Boldt HB, Hansen S, Lathia JD, Kristensen BW.

J Neurooncol. 2017 Oct;135(1):107-117. doi: 10.1007/s11060-017-2555-0. Epub 2017 Jul 4.

31.

Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.

Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R; Nordic Clinical Brain Tumor Study Group (NCBTSG).

Acta Oncol. 2017 Dec;56(12):1776-1785. doi: 10.1080/0284186X.2017.1332780. Epub 2017 Jul 4.

PMID:
28675067
32.

APNG as a prognostic marker in patients with glioblastoma.

Fosmark S, Hellwege S, Dahlrot RH, Jensen KL, Derand H, Lohse J, Sørensen MD, Hansen S, Kristensen BW.

PLoS One. 2017 Jun 29;12(6):e0178693. doi: 10.1371/journal.pone.0178693. eCollection 2017.

33.

Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.

Dahlrot RH, Dowsett J, Fosmark S, Malmström A, Henriksson R, Boldt H, de Stricker K, Sørensen MD, Poulsen HS, Lysiak M, Söderkvist P, Rosell J, Hansen S, Kristensen BW.

Neuropathol Appl Neurobiol. 2018 Feb;44(2):172-184. doi: 10.1111/nan.12415. Epub 2017 Jun 28.

PMID:
28574607
34.

The gene expression and immunohistochemical time-course of diphenylcyclopropenone-induced contact allergy in healthy humans following repeated epicutaneous challenges.

Mose KF, Burton M, Thomassen M, Andersen F, Kruse TA, Tan Q, Skov L, Røpke MA, Litman T, Clemmensen O, Kristensen BW, Friedmann PS, Andersen KE.

Exp Dermatol. 2017 Oct;26(10):926-933. doi: 10.1111/exd.13345. Epub 2017 Jul 9.

PMID:
28370374
35.

Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.

Jensen SS, Petterson SA, Halle B, Aaberg-Jessen C, Kristensen BW.

BMC Cancer. 2017 Mar 7;17(1):178. doi: 10.1186/s12885-017-3162-3.

36.

Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.

Ramachandran RK, Sørensen MD, Aaberg-Jessen C, Hermansen SK, Kristensen BW.

PLoS One. 2017 Feb 24;12(2):e0172234. doi: 10.1371/journal.pone.0172234. eCollection 2017.

37.

Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.

Munthe S, Halle B, Boldt HB, Christiansen H, Schmidt S, Kaimal V, Xu J, Zabludoff S, Mollenhauer J, Poulsen FR, Kristensen BW.

J Neurooncol. 2017 Mar;132(1):45-54. doi: 10.1007/s11060-016-2356-x. Epub 2017 Jan 13.

38.

Spontaneous ischaemic stroke lesions in a dog brain: neuropathological characterisation and comparison to human ischaemic stroke.

Thomsen BB, Gredal H, Wirenfeldt M, Kristensen BW, Clausen BH, Larsen AE, Finsen B, Berendt M, Lambertsen KL.

Acta Vet Scand. 2017 Jan 13;59(1):7. doi: 10.1186/s13028-016-0275-7.

39.
40.

Highly Effective Auger-Electron Therapy in an Orthotopic Glioblastoma Xenograft Model using Convection-Enhanced Delivery.

Thisgaard H, Halle B, Aaberg-Jessen C, Olsen BB, Therkelsen AS, Dam JH, Langkjær N, Munthe S, Någren K, Høilund-Carlsen PF, Kristensen BW.

Theranostics. 2016 Sep 29;6(12):2278-2291. eCollection 2016.

41.

Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.

Munthe S, Sørensen MD, Thomassen M, Burton M, Kruse TA, Lathia JD, Poulsen FR, Kristensen BW.

J Neurooncol. 2016 Oct;130(1):53-62. Epub 2016 Aug 10.

42.

Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.

Aaberg-Jessen C, Halle B, Jensen SS, Müller S, Rømer UM, Pedersen CB, Brünner N, Kristensen BW.

J Neurooncol. 2016 Dec;130(3):439-448. Epub 2016 Sep 12.

43.

Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.

Jensen SS, Meyer M, Petterson SA, Halle B, Rosager AM, Aaberg-Jessen C, Thomassen M, Burton M, Kruse TA, Kristensen BW.

PLoS One. 2016 Jul 25;11(7):e0159746. doi: 10.1371/journal.pone.0159746. eCollection 2016.

44.

Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling.

Clausen BH, Degn M, Sivasaravanaparan M, Fogtmann T, Andersen MG, Trojanowsky MD, Gao H, Hvidsten S, Baun C, Deierborg T, Finsen B, Kristensen BW, Bak ST, Meyer M, Lee J, Nedospasov SA, Brambilla R, Lambertsen KL.

Sci Rep. 2016 Jul 7;6:29291. doi: 10.1038/srep29291.

45.

Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.

Munthe S, Petterson SA, Dahlrot RH, Poulsen FR, Hansen S, Kristensen BW.

PLoS One. 2016 May 12;11(5):e0155106. doi: 10.1371/journal.pone.0155106. eCollection 2016.

46.

Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.

Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, Sinyuk M, Wu Q, Jarrar A, Kim SH, Fox PL, Nakano I, Rich JN, Ransohoff RM, Finke J, Kristensen BW, Vogelbaum MA, Lathia JD.

Stem Cells. 2016 Aug;34(8):2026-39. doi: 10.1002/stem.2393. Epub 2016 May 27.

47.

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.

Blaabjerg M, Ruprecht K, Sinnecker T, Kondziella D, Niendorf T, Kerrn-Jespersen BM, Lindelof M, Lassmann H, Kristensen BW, Paul F, Illes Z.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e226. doi: 10.1212/NXI.0000000000000226. eCollection 2016 Jun.

48.

Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.

Christlieb SB, Strandholdt CN, Olsen BB, Mylam KJ, Larsen TS, Nielsen AL, Rohde M, Gerke O, Olsen KE, Møller MB, Kristensen BW, Abildgaard N, Alavi A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1824-36. doi: 10.1007/s00259-016-3385-6. Epub 2016 Apr 22.

PMID:
27102266
49.

Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures.

Halle B, Thomassen M, Venkatesan R, Kaimal V, Marcusson EG, Munthe S, Sørensen MD, Aaberg-Jessen C, Jensen SS, Meyer M, Kruse TA, Christiansen H, Schmidt S, Mollenhauer J, Schulz MK, Andersen C, Kristensen BW.

J Neurooncol. 2016 Jul;128(3):395-404. doi: 10.1007/s11060-016-2125-x. Epub 2016 Apr 11.

PMID:
27063952
50.

Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.

Clausen BH, Lambertsen KL, Dagnæs-Hansen F, Babcock AA, von Linstow CU, Meldgaard M, Kristensen BW, Deierborg T, Finsen B.

Acta Neuropathol. 2016 May;131(5):775-91. doi: 10.1007/s00401-016-1541-5. Epub 2016 Feb 9.

Supplemental Content

Loading ...
Support Center